|
1
|
Kivelä T: The epidemiological challenge of
the most frequent eye cancer: retinoblastoma, an issue of birth and
death. Br J Ophthalmol. 93:1129–1131. 2009.PubMed/NCBI
|
|
2
|
Mehta M, Sethi S, Pushker N, Kashyap S,
Sen S, Bajaj MS and Ghose S: Retinoblastoma. Singapore Med J.
53:128–135. 2012.
|
|
3
|
Oremek GM, Sauer-Eppel H and Bruzdziak TH:
Value of tumour and inflammatory markers in lung cancer. Anticancer
Res. 27:1911–1915. 2007.PubMed/NCBI
|
|
4
|
Hervás Benito I, Rivas Sánchez A, Bello
Arques P, et al: Value of 123I-MIBG scanning, neuron-specific
enolase and serum ferritin in the diagnosis and follow-up of
patients with neuroblastoma. Rev Esp Med Nucl. 20:369–376. 2001.(In
Spanish).
|
|
5
|
Wu Z, Mao Y, Yang H, Pan S and Chen Z: The
determination of neuron-specific enolase of serum in the diagnosis
and supervision of retinoblastoma. Chin J Ophthalmol. 34:117–120.
1998.(In Chinese).
|
|
6
|
Wu Z, Yang H, Pan S and Chen Z:
Electrophoretic determination of aqueous and serum neuron-specific
enolase in the diagnosis of retinoblastoma. Eye science. 13:12–16.
1997.PubMed/NCBI
|
|
7
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stefani G and Slack FJ: Small non-coding
RNAs in animal development. Nat Rev Mol Cell Biol. 9:219–230. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang J, Lee EJ, Gusev Y and Schmittgen
TD: Real-time expression profiling of microRNA precursors in human
cancer cell lines. Nucleic Acids Res. 33:5394–5403. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen X, Ba Y, Ma L, et al:
Characterization of microRNAs in serum: a novel class of biomarkers
for diagnosis of cancer and other diseases. Cell Res. 18:997–1006.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gilad S, Meiri E, Yogev Y, et al: Serum
microRNAs are promising novel biomarkers. PLoS One. 3:e31482008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mu G, Liu H, Zhou F, Xu X, Jiang H, Wang Y
and Qu Y: Correlation of overexpression of HMGA1 and HMGA2 with
poor tumor differentiation, invasion, and proliferation associated
with let-7 down-regulation in retinoblastomas. Hum Pathol.
41:493–502. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Motoyama K, Inoue H, Nakamura Y, Uetake H,
Sugihara K and Mori M: Clinical significance of high mobility group
A2 in human gastric cancer and its relationship to let-7 microRNA
family. Clin Cancer Res. 14:2334–2340. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qian ZR, Asa SL, Siomi H, et al:
Overexpression of HMGA2 relates to reduction of the let-7 and its
relationship to clinicopathological features in pituitary adenomas.
Mod Pathol. 22:431–441. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rahman MM, Qian ZR, Wang EL, et al:
Frequent overexpression of HMGA1 and 2 in gastroenteropancreatic
neuroendocrine tumours and its relationship to let-7
downregulation. Br J Cancer. 100:501–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takamizawa J, Konishi H, Yanagisawa K, et
al: Reduced expression of the let-7 microRNAs in human lung cancers
in association with shortened postoperative survival. Cancer Res.
64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lawrie CH, Gal S, Dunlop HM, et al:
Detection of elevated levels of tumour-associated microRNAs in
serum of patients with diffuse large B-cell lymphoma. Br J
Haematol. 141:672–675. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hsieh IS, Chang KC, Tsai YT, et al:
MicroRNA-320 suppresses the stem cell-like characteristics of
prostate cancer cells by downregulating the Wnt/beat-catenin
signaling pathway. Carcinogenesis. 34:530–538. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao JJ, Yang J, Lin J, et al:
Identification of miRNAs associated with tumorigenesis of
retinoblastoma by miRNA microarray analysis. Childs Nerv Syst.
25:13–20. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chan SH, Wu CW, Li AF, Chi CW and Lin WC:
miR-21 microRNA expression in human gastric carcinomas and its
clinical association. Anticancer Res. 28:907–911. 2008.PubMed/NCBI
|
|
22
|
Kumar S, Keerthana R, Pazhanimuthu A and
Perumal P: Overexpression of circulating miRNA-21 and miRNA-146a in
plasma samples of breast cancer patients. Indian J Biochem Biophys.
50:210–214. 2013.PubMed/NCBI
|
|
23
|
Toiyama Y, Takahashi M, Hur K, et al:
Serum miR-21 as a diagnostic and prognostic biomarker in colorectal
cancer. J Natl Cancer Inst. 105:849–859. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Y, Li W, Ouyang Q, Hu S and Tang J:
Detection of lung cancer with blood microRNA-21 expression levels
in Chinese population. Oncol Lett. 2:991–994. 2011.PubMed/NCBI
|
|
25
|
Dimaras H, Kimani K, Dimba EA, Gronsdahl
P, White A, Chan HS and Gallie BL: Retinoblastoma. Lancet.
379:1436–1446. 2012. View Article : Google Scholar
|
|
26
|
Kivelä T: Neuron-specific enolase in
retinoblastoma: An immunohistochemical study. Acta Ophthalmol
(Copenh). 64:19–25. 1986.PubMed/NCBI
|
|
27
|
Nakajima T, Kato K, Kaneko A, et al: High
concentrations of enolase, alpha- and gamma-subunits, in the
aqueous humor in cases of retinoblastoma. Am J Ophthalmol.
101:102–106. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nucci P, Tredici G, Manitto MP, et al:
Neuron-specific enolase in ophthalmology. Arch Ital Anat Embriol.
96:73–76. 1991.(In Italian).
|
|
29
|
Beta M, Venkatesan N, Vasudevan M,
Vetrivel U, Khetan V and Krishnakumar S: Identification and in
silico analysis of retinoblastoma serum microRNA profile and gene
targets towards prediction of novel serum biomarkers. Bioinform
Biol Insights. 7:21–34. 2013.PubMed/NCBI
|
